Initial experience of combined use of photodynamic diagnosis and narrow band imaging for detection of flat urothelial lesion

International Journal of Clinical Oncology

Volumn 20, Issue 3, 2015, Pages 593-597

  Naya, Yoshio ^a   Oishi, Masakastu ^a   Yamada, Yasunori ^a   Ueda, Takashi ^a   Fujihara, Atsuko ^a   Nakanishi, Hiroyuki ^a   Naito, Yasuyuki ^a   Nakamura, Terukazu ^a   Hongo, Fumiya ^a   Kamoi, Kazumi ^a   Okihara, Koji ^a   Miki, Tsuneharu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Carcinoma in situ of bladder; Narrow band imaging; Photodynamic diagnosis

Indexed keywords

AMINOLEVULINIC ACID;

ARTICLE; BLADDER BIOPSY; BLADDER CARCINOMA; BLADDER DYSPLASIA; CANCER DIAGNOSIS; CANCER PATIENT; CARCINOMA IN SITU; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CYSTECTOMY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DYSPLASIA; HUMAN; NARROW BAND IMAGING; PHOTODYNAMIC DIAGNOSIS; PHOTODYNAMIC DIAGNOSIS SYSTEM; PHOTODYNAMICS; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UROLOGICAL DIAGNOSTIC DEVICE; BIOPSY; PATHOLOGY; TRANSILLUMINATION; URINARY BLADDER NEOPLASMS; UROTHELIUM;

BIOPSY; CARCINOMA IN SITU; HUMANS; NARROW BAND IMAGING; TRANSILLUMINATION; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 84930666186     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-014-0748-5     Document Type: Article

References (22)

1. Ferlay J, Shin HR, Bray F, Forman D et al (2010) GLOBOCAN 2008 v1.2, cancer incidence and mortality worldwide: IARC cancer base no. 10. International Agency for Research on Cancer, Lyon
2. Matsuda T, Marugame T, Kamo K et al (2011) The Japan Cancer Surveillance Research Group. Cancer incidence and incidence rates in Japan in 2005: based on data from 12 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol 41:139–147
3. Richterstetter M, Wullich B, Amann K et al (2012) The value of extended transurethral resection of bladder tumour (TURBT) in the treatment of bladder cancer. BJU Int 110:E76–E79
4. Brausi M, Collette L, Kurth K et al (2002) Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol 41:523–531
5. Denzinger S, Burger M, Walter B et al (2007) Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study. Urology 69:675–679
6. Stenzl A, Burger M, Fradet Y et al (2010) Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer. J Urol 184:1907–1913
7. Hermann GG, Mogensen K, Carlsson S et al (2011) Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in Ta/T1 patients: a randomized 2-centre study. BJU Int 108:297–303
8. Schumacher MC, Holmang S, Davidsson T et al (2010) Transurethral resection of non-muscle-invasive bladder transitional cell cancers with or without 5-aminolevulinic acid under visible and fluorescent light: results of a prospective, randomised, multicentre study. Eur Urol 57:293–299
9. Krammer B, Plaetzer K (2008) ALA and its clinical impact, from bench to bedside. Photochem Photobiol Sci 7:283–289
10. Blanco S, Raber M, Eugenio Leone B, Nespoli L, Grasso M (2010) Early detection of urothelial premalignant lesions using hexaminolevulinate fluorescence cystoscopy in high risk patients. J Transl Med 8:122
11. Patel P, Bryan RT, Wallace MA (2011) Emerging endoscopic and photodynamic techniques for bladder cancer detection and surveillance. ScientificWorldJournal 11:2550–2558
12. Mowatt G, Zhu S, Kilonzo M et al (2010) Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer. Health Technol Assess 14:1–331
13. Bryan RT, Billingham LJ, Wallace DMA (2008) Narrow-band imaging flexible cystoscopy in the detection of recurrent urothelial cancer of the bladder. BJU Int 101:702–705
14. Tatsugami K, Kuroiwa K, Kamoto T et al (2010) Evaluation of narrow-band imaging as a complementary method for the detection of bladder cancer. J Endourol 24:1807–1811
15. Inoue K, Fukuhara H, Shimamoto T et al (2012) Comparison between intravesical and oral administration of 5-aminolevulinic acid in the clinical benefit of photodynamic diagnosis for nonmuscle invasive bladder cancer. Cancer 118:1062–1074
16. Montironi R, Lopez-Beltran A (2005) The 2004 WHO classification of bladder tumors: a summary and commentary. Int J Surg Pathol 13:143–153
17. Zaak D, Kriegmair M, Stepp H et al (2001) Endoscopic detection of transitional cell carcinoma with 5-aminolevulinic acid: results of 1012 fluorescence endoscopies. Urology 57:690–694
18. Hungerhuber E, Stepp H, Kriegmair M et al (2007) Seven years’ experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder. Urology 69:260–264
19. Daniltchenco DI, Riedel CR, Sachs MD et al (2005) Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study. J Urol 174:2129–2133
20. Lapini A, Minervini A, Masala A et al (2012) A comparison of hexaminolevulinate (Hexvix(®)) fluorescence cystoscopy and white-light cystoscopy for detection of bladder cancer: results of the HeRo observational study. Surg Endosc 26:3634–3641
21. Zheng C, Lv Y, Zhong Q, Wang R, Jian Q (2012) Narrow band imaging diagnosis of bladder cancer systematic review and meta-analysis. BJU Int 110:680–687
22. Cauberg EC, Kloen S, Visser M et al (2010) Narrowband imaging cystoscopy improves the detection of non-muscle invasive bladder cancer. Urology 76:658–663